Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Stuart MacDonald joins Aquila Capital as Managing Director

Monday, October 15, 2012
Opalesque Industry Update:Aquila Capital, has announced the appointment of industry expert, Stuart MacDonald as Managing Director to assist in developing Aquila’s growing institutional business.

Stuart joins Aquila Capital from Gems Advisors, having previously worked in a senior capacity at firms such as Henderson Global Investors, West Merchant Bank and Buchanan Partners. In addition to many years of developing UK and international institutional clients, Stuart hosts the award-winning investment radio show, “The Naked Short Club” on London’s Resonance 104.4FM.

“I am delighted to welcome Stuart to the team. Stuart is a highly respected leader with extensive industry knowledge and an enviable track record in business development in alternative investment management. I’m confident that his proven expertise and broad experience in the market will support our international growth strategy as Aquila continues to expand in Europe and beyond," said Roland Schulz, Managing Director at Aquila Capital.

“Aquila Capital is an exciting opportunity. It was one of the first alternative investment managers to use UCITS vehicles without compromising the performance of its strategies, e.g. for its Risk Parity funds and a “trend-plus” CTA fund. Aquila is also active and innovative in the growing arena of Real Assets, often with an SRI slant that is increasingly significant to investors," said Stuart MacDonald, Managing Director.

Aquila Capital

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for